NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,239 filers reported holding NOVARTIS A G in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,370 | +16.1% | 12,870 | +5.5% | 0.63% | +132.0% |
| Q1 2024 | $1,180 | -2.1% | 12,199 | +2.2% | 0.27% | -13.1% |
| Q4 2023 | $1,205 | +5.0% | 11,933 | +5.9% | 0.31% | -4.6% |
| Q3 2023 | $1,148 | +2.7% | 11,269 | +1.7% | 0.33% | -43.3% |
| Q2 2023 | $1,118 | +9.8% | 11,084 | +0.1% | 0.58% | +124.9% |
| Q1 2023 | $1,018 | -48.2% | 11,068 | -48.9% | 0.26% | -7.6% |
| Q4 2022 | $1,964 | -99.7% | 21,660 | +115.5% | 0.28% | +27.5% |
| Q3 2022 | $764,000 | -3.4% | 10,052 | +7.5% | 0.22% | +1.9% |
| Q2 2022 | $791,000 | +7.8% | 9,355 | +11.9% | 0.21% | +7.5% |
| Q1 2022 | $734,000 | +24.4% | 8,359 | +23.9% | 0.20% | +31.8% |
| Q4 2021 | $590,000 | +0.7% | 6,747 | -5.8% | 0.15% | -55.8% |
| Q3 2021 | $586,000 | -3.1% | 7,166 | +8.1% | 0.34% | +119.2% |
| Q2 2021 | $605,000 | +151.0% | 6,627 | +135.2% | 0.16% | +160.0% |
| Q1 2021 | $241,000 | – | 2,818 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |